Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.
Shenzhen Second People's Hospital
Shenzhen Second People's Hospital
Shenzhen Second People's Hospital
Institut Bergonié
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
First Affiliated Hospital of Harbin Medical University
Heidelberg University
Newcastle University
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Vanderbilt-Ingram Cancer Center
Northwestern University
Fred Hutchinson Cancer Center
Tufts Medical Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center